Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Fig. 2

SARS-CoV-2 specific antibody responses in re-infected individuals. Two participants had a laboratory-confirmed SARS-CoV-2 reinfection during the follow-up period of the study. They were both re-infected during the beta variant wave. Kinetics of anti-Spike, anti-RBD, and neutralisation activity in serum of A 46-year-old male and B 49-year-old female. S, full-length Spike; RBD, receptor-binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us